CHSS Advice Line
No one should have to recover alone. We’re here to support you with our services, resources and health information.
Resources Hub
Download and order a range of resources to help you manage your condition.
Scotland’s Stories
Read the inspiring stories of the amazing people who are living life to the full with a long-term health condition.
Get free, confidential advice and support from our Advice Line practitioners. No question is too big or too small.
Advice Line
Every day people in Scotland are leaving hospital feeling scared and alone. But you can help us change this.
Fundraising Events
Join Scotland’s Fundraising Heroes by getting involved with one of our exciting events or challenges!
Visit our charity shops
Use our Store Finder to find your local shop or boutique and pop in to see us today.
You can make sure stroke survivors in Scotland like Tim get the support they need after returning home from hospital.
Donate
We are Scotland’s largest health charity working to help people with chest, heart and stroke conditions live life to the full.
Social Media – @chsscotland
Incredible impact
Find out about the incredible impact your support is having and the amazing things you’re helping to achieve.
Search our current job opportunities to find a new role that’s rewarding, exciting and allows you to make a real difference every day.
Work With Us
Type: Chest
Grant holder: Dr Manjit Sidhu (Supervisor: Dr Adam Hill); Department of Respiratory Medicine, Royal Infirmary, Edinburgh
Amount Awarded: £119,085 over two years
Year: 2013 - Finished
An obstructive lung disease, bronchiectasis is a common long-term condition caused by permanent damage to the airways. Patients suffer with recurrent cough, sputum production and frequent infections. Antibiotics can help but it is difficult for doctors to be sure when is the right time to prescribe. This fellowship will explore whether monitoring the amount of bacteria in the sputum can help doctors and nurses decide when an antibiotic is needed, as in dealing with urine infections. Overall, it will help design future treatment studies for patients and help address current concerns over antibiotic prescribing.